LifeMD, Inc.

NasdaqGM:LFMD Stock Report

Market Cap: US$554.9m

LifeMD Management

Management criteria checks 3/4

LifeMD's CEO is Justin Schreiber, appointed in Jan 2022, has a tenure of 3.42 years. total yearly compensation is $1.06M, comprised of 29.3% salary and 70.7% bonuses, including company stock and options. directly owns 6.11% of the company’s shares, worth $33.93M. The average tenure of the management team and the board of directors is 3.4 years and 6.6 years respectively.

Key information

Justin Schreiber

Chief executive officer

US$1.1m

Total compensation

CEO salary percentage29.27%
CEO tenure3.4yrs
CEO ownership6.1%
Management average tenure3.4yrs
Board average tenure6.6yrs

Recent management updates

Recent updates

LifeMD Might Run Higher

May 09

LifeMD, Inc. Beat Analyst Profit Forecasts, And Analysts Have New Estimates

May 09
LifeMD, Inc. Beat Analyst Profit Forecasts, And Analysts Have New Estimates

LifeMD, Inc.'s (NASDAQ:LFMD) Shares Leap 50% Yet They're Still Not Telling The Full Story

May 07
LifeMD, Inc.'s (NASDAQ:LFMD) Shares Leap 50% Yet They're Still Not Telling The Full Story
author-image

New HRT, GLP-1 And Medicare Programs Will Elevate Care

Expansion in Medicare programs and integration with Gifthealth are set to enhance LifeMD's market reach and boost revenue through improved patient retention.
author-image

LifeMD is a diamond in the making

Telehealth is the future of healthcare in america and around the world. Most people don’t want to wait hours in the hospital or even weeks for an appointment. Telehealth offers those services the same

A Look At The Intrinsic Value Of LifeMD, Inc. (NASDAQ:LFMD)

Mar 31
A Look At The Intrinsic Value Of LifeMD, Inc. (NASDAQ:LFMD)

It's Down 27% But LifeMD, Inc. (NASDAQ:LFMD) Could Be Riskier Than It Looks

Mar 08
It's Down 27% But LifeMD, Inc. (NASDAQ:LFMD) Could Be Riskier Than It Looks

LifeMD: Dilution Ramps Up As Revenue Moves Higher

Feb 01

LifeMD, Inc.'s (NASDAQ:LFMD) Intrinsic Value Is Potentially 82% Above Its Share Price

Dec 06
LifeMD, Inc.'s (NASDAQ:LFMD) Intrinsic Value Is Potentially 82% Above Its Share Price

LifeMD: A Story I Want A Small Piece Of

Dec 04

LifeMD, Inc.'s (NASDAQ:LFMD) Shares Leap 31% Yet They're Still Not Telling The Full Story

Nov 09
LifeMD, Inc.'s (NASDAQ:LFMD) Shares Leap 31% Yet They're Still Not Telling The Full Story

LifeMD: Are The Commons Too Cheap?

Sep 23

LifeMD: Selling WorkSimpli Could Be A Catalyst

Sep 10

It's Down 27% But LifeMD, Inc. (NASDAQ:LFMD) Could Be Riskier Than It Looks

Aug 16
It's Down 27% But LifeMD, Inc. (NASDAQ:LFMD) Could Be Riskier Than It Looks

LifeMD: High Growth GLP-1 Telehealth Play At A Discount

Jul 31

LifeMD: Pairing GLP-1 Agonists With Virtual Healthcare

Jun 11

LifeMD: Moving Towards Profitability

May 22

Is LifeMD (NASDAQ:LFMD) Using Debt Sensibly?

Apr 25
Is LifeMD (NASDAQ:LFMD) Using Debt Sensibly?

Even With A 29% Surge, Cautious Investors Are Not Rewarding LifeMD, Inc.'s (NASDAQ:LFMD) Performance Completely

Mar 30
Even With A 29% Surge, Cautious Investors Are Not Rewarding LifeMD, Inc.'s (NASDAQ:LFMD) Performance Completely

LifeMD: Results And Guidance Point To Continued Strength In Weight Management Program

Mar 13

LifeMD's 2024: Striking A Balance Between Rapid Expansion And Sustainability

Jan 22

LifeMD: A GLP-1 Play With A Kicker

Jan 11

Is LifeMD, Inc. (NASDAQ:LFMD) Potentially Undervalued?

Jan 05
Is LifeMD, Inc. (NASDAQ:LFMD) Potentially Undervalued?

Take Care Before Jumping Onto LifeMD, Inc. (NASDAQ:LFMD) Even Though It's 34% Cheaper

Jan 05
Take Care Before Jumping Onto LifeMD, Inc. (NASDAQ:LFMD) Even Though It's 34% Cheaper

Does This Valuation Of LifeMD, Inc. (NASDAQ:LFMD) Imply Investors Are Overpaying?

Dec 03
Does This Valuation Of LifeMD, Inc. (NASDAQ:LFMD) Imply Investors Are Overpaying?

Investors Still Aren't Entirely Convinced By LifeMD, Inc.'s (NASDAQ:LFMD) Revenues Despite 38% Price Jump

Apr 17
Investors Still Aren't Entirely Convinced By LifeMD, Inc.'s (NASDAQ:LFMD) Revenues Despite 38% Price Jump

Analysts Are Betting On LifeMD, Inc. (NASDAQ:LFMD) With A Big Upgrade This Week

Nov 17
Analysts Are Betting On LifeMD, Inc. (NASDAQ:LFMD) With A Big Upgrade This Week

LifeMD launches at-home screening kits for breast, colon cancers

Sep 14

LifeMD Non-GAAP EPS of -$0.22 beats by $0.01, revenue of $30.5M misses by $1.45M

Aug 11

CEO Compensation Analysis

How has Justin Schreiber's remuneration changed compared to LifeMD's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2025n/an/a

-US$14m

Dec 31 2024US$1mUS$311k

-US$22m

Sep 30 2024n/an/a

-US$26m

Jun 30 2024n/an/a

-US$27m

Mar 31 2024n/an/a

-US$26m

Dec 31 2023US$889kUS$300k

-US$24m

Sep 30 2023n/an/a

-US$32m

Jun 30 2023n/an/a

-US$33m

Mar 31 2023n/an/a

-US$39m

Dec 31 2022US$255kUS$255k

-US$49m

Sep 30 2022n/an/a

-US$55m

Jun 30 2022n/an/a

-US$61m

Mar 31 2022n/an/a

-US$64m

Dec 31 2021US$180kUS$180k

-US$62m

Sep 30 2021n/an/a

-US$75m

Jun 30 2021n/an/a

-US$85m

Mar 31 2021n/an/a

-US$73m

Dec 31 2020US$9mUS$180k

-US$63m

Sep 30 2020n/an/a

-US$32m

Jun 30 2020n/an/a

-US$9m

Mar 31 2020n/an/a

-US$5m

Dec 31 2019US$876kn/a

-US$3m

Sep 30 2019n/an/a

-US$3m

Jun 30 2019n/an/a

-US$3m

Mar 31 2019n/an/a

-US$3m

Dec 31 2018US$460kn/a

-US$2m

Compensation vs Market: Justin's total compensation ($USD1.06M) is below average for companies of similar size in the US market ($USD2.69M).

Compensation vs Earnings: Justin's compensation has increased whilst the company is unprofitable.

CEO

Justin Schreiber (42 yo)

3.4yrs
Tenure
US$1,063,459
Compensation

Mr. Justin Schreiber served as an Independent Director at Quantum Computing Inc until September 22, 2021. Mr. Schreiber has been Chairman of the Board at LifeMD, Inc. (formerly known as Conversion Labs, In...

Leadership Team

NamePositionTenureCompensationOwnership
Justin Schreiber
Chairman & CEO3.4yrsUS$1.06m6.11%
$ 33.9m
Dennis Wijnker
Chief Technology Officer3.5yrsUS$1.31m0.24%
$ 1.3m
Shane Biffar
Chief Compliance Officer & Deputy General Counsel1.8yrsUS$896.81k0.088%
$ 488.4k
Marc Benathen
Chief Financial Officer4.3yrsUS$2.60m1.02%
$ 5.7m
Maria Stan
Chief Accounting Officer & Controller4.3yrsno data0.41%
$ 2.3m
Eric Yecies
Chief Legal Officer4.6yrsUS$769.48k0.81%
$ 4.5m
Jessica Friedeman
Chief Marketing Officer2.4yrsno data0.37%
$ 2.1m
Stefan Galluppi
Chief Innovation Officer2.4yrsUS$1.60m0.36%
$ 2.0m
Nicholas Alvarez
Chief Acquisition Officer & Head of Customer Acquisition7.4yrsUS$1.64m1.28%
$ 7.1m
James Porte
Senior Vice President of Patient Experience3.3yrsno datano data
Gerard Rotonda
Managing Director of Strategy & Business Development1.6yrsno datano data
Julian Cohen
Senior VP of Behavioral Health & Clinical Operationsless than a yearno datano data
3.4yrs
Average Tenure
43.5yo
Average Age

Experienced Management: LFMD's management team is considered experienced (3.4 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Justin Schreiber
Chairman & CEO8yrsUS$1.06m6.11%
$ 33.9m
Joseph DiTrolio
Independent Director10.8yrsUS$212.80k0.51%
$ 2.8m
John Strawn
Independent Director13.9yrsUS$430.92k0.86%
$ 4.8m
Roberto Simon
Independent Director4.6yrsUS$451.90k0.29%
$ 1.6m
Jeremy Fine
Member of Medical Advisory Board5.2yrsno datano data
Michael Borenstein
Member of Advisory Boardno dataUS$12.30kno data
Jeff Toll
Member of Medical Advisory Board5yrsno datano data
Jordan Iversen
Member of Advisory Boardno datano datano data
Christopher Reed
Member of Advisory Boardno datano datano data
Lilliana Ramirez
Member of Advisory Boardno datano datano data
Steven Shapiro
Member of Advisory Boardno datano datano data
Jack Gilbert
Member of Advisory Boardno datano datano data
6.6yrs
Average Tenure
55yo
Average Age

Experienced Board: LFMD's board of directors are considered experienced (6.6 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/06/01 19:23
End of Day Share Price 2025/05/30 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

LifeMD, Inc. is covered by 12 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Anderson SchockB. Riley Securities, Inc.
Kyle BauserB. Riley Securities, Inc.
David LarsenBTIG